Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation ...
Leapman, MD, MHS, associate professor of urology at Yale University, addresses a critical and often overlooked limitation in the current landscape of prostate cancer biomarkers: while these tools have ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Jozefina Casuscelli discussing the optimal management of de-novo ...
Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results